AVANIR Pharmaceuticals - Class A

FRA:AV2B (USA)   Class A
€ 14.37 (-0.19%) Jan 13
At Loss
P/B:
12.03
Market Cap:
€ 2.69B ($ 2.91B)
Enterprise V:
€ 2.69B ($ 2.91B)
Volume:
-
Avg Vol (2M):
-

AVANIR Pharmaceuticals Valuation Measures